GHENIMA CHERID: Open Payments
NPI 1710263363 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 4 payments from 3 companies in 2025. Trend: 2023 $631 · 2024 $538 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $126 |
| Novo Nordisk Inc | 1 | $122 |
| Paratek Pharmaceuticals, Inc. | 2 | $88 |
Products named: TAVNEOS, Ozempic, NUZYRA.
Industry payments across TX — which companies pay providers there.
